It's so huge. Hard to grasp. It's incredible.
The firm's Q3 earnings easily beat Wall Street's expectations.
Let's see if UNH and CI are what the doctor ordered.
Is Teladoc's merger with Livongo Health a 'game changer' for the stock?
The company is set to report earnings Tuesday.
With 33 years of consecutive dividend increases, this health care name is a member of the Dividend Aristocrats Index.
Right now, the market is furiously trying to price in a Blue Wave, and the health care sector is getting clobbered. But here's how I think things play out.
Let's check the charts of the health plan provider.
We are back to square one except for one positive and one negative.
The stock is simply too cheap, given its strong results to begin 2020, and a highly profitable business model that generates huge amounts of cash flow.